General Information of the Compound
Compound ID
CP0575338
Compound Name
5-ethyl-1-[(4-ethylphenyl)methyl]-N-(furan-2-ylmethyl)benzimidazol-2-amine
    Show/Hide
Structure
Formula
C23H25N3O
Molecular Weight
359.473
Canonical SMILES
CCc1ccc(Cn2c(NCc3ccco3)nc3cc(CC)ccc23)cc1
    Show/Hide
InChI
InChI=1S/C23H25N3O/c1-3-17-7-9-19(10-8-17)16-26-22-12-11-18(4-2)14-21(22)25-23(26)24-15-20-6-5-13-27-20/h5-14H,3-4,15-16H2,1-2H3,(H,24,25)
    Show/Hide
InChIKey
PALNGWWASYGRMM-UHFFFAOYSA-N
Physicochemical Property
logP
5.4145
Rotatable Bonds
7
Heavy Atom Count
27
Polar Areas
42.99
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 168297839
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05452, Short transient receptor potential channel 5
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 2300 nM
   TI
   LI
   LO
   TS